Lecanemab: Alzheimer’s drug study yields positive results
- 28-Sep-2022
An experimental Alzheimer’s drug made by Eisai and Biogen slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs. Multiple drugmakers have so far tried and failed to find an effective treatment […]